Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr;23(4):461-467.
doi: 10.1634/theoncologist.2017-0391. Epub 2017 Nov 30.

Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey

Christian Rothermundt  1 , Galina F Fischer  2 , Sebastian Bauer  3 , Jean-Yves Blay  4 , Viktor Grünwald  5 , Antoine Italiano  6 , Bernd Kasper  7 , Attila Kollár  8 , Lars H Lindner  9 , Aisha Miah  10 , Stefan Sleijfer  11 , Silvia Stacchiotti  12 , Paul Martin Putora  2   13
Affiliations
Review

Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey

Christian Rothermundt et al. Oncologist. 2018 Apr.

Abstract

Background: The management of localized extremity soft tissue sarcomas (STS) is challenging and the role of pre- and postoperative chemotherapy is unclear and debated among experts.

Materials and methods: Medical oncology experts of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group were asked to participate in this survey on the use of pre- and postoperative chemotherapy in STS. Experts from 12 centers in Belgium, France, Germany, Great Britain, Italy, Switzerland, and The Netherlands agreed to participate and provided their treatment algorithm. Answers were converted into decision trees based on the objective consensus methodology. The decision trees were used as a basis to identify consensus and discrepancies.

Results: Several criteria used for decision-making in extremity STS were identified: chemosensitivity, fitness, grading, location, and size. In addition, resectability and resection status were relevant in the pre- and postoperative setting, respectively. Preoperative chemotherapy is considered in most centers for marginally resectable tumors only. Yet, in some centers, neoadjuvant chemotherapy is used routinely and partially combined with hyperthermia. Although most centers do not recommend postoperative chemotherapy, some offer this treatment on a regular basis. Radiotherapy is an undisputed treatment modality in extremity STS.

Conclusion: Due to lacking evidence on the utility of pre- and postoperative chemotherapy in localized extremity STS, treatment strategies vary considerably among European experts. The majority recommended neoadjuvant chemotherapy for marginally resectable grade 2-3 tumors; the majority did not recommend postoperative chemotherapy in any setting.

Implications for practice: The management of localized extremity soft tissue sarcomas (STS) is challenging and the role of pre- and postoperative chemotherapy is unclear and debated among experts. This study analyzed the decision-making process among 12 European experts on systemic therapy for STS. A wide range of recommendations among experts regarding the use of perioperative chemotherapy was discovered. Discrepancies in the use of decision criteria were also uncovered, including the definition of what constitutes high-risk cancer, which is a basis for many to recommend chemotherapy. Before any standardization is possible, a common use of decision criteria is necessary.

Keywords: Adjuvant; Chemotherapy; Decision‐making; Expert opinion; Neoadjuvant; Soft tissue sarcoma.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

Figures

Figure 1.
Figure 1.
Sample decision tree illustrating the input from one center on preoperative chemotherapy. Abbreviations: G, grade; STS, soft tissue sarcomas.
Figure 2.
Figure 2.
Preoperative chemotherapy mode. Abbreviations: G, grade; STS, soft tissue sarcomas.
Figure 3.
Figure 3.
Postoperative chemotherapy mode. Abbreviations: G, grade; STS, soft tissue sarcomas.
Figure 4.
Figure 4.
Distribution of chemotherapy versus no chemotherapy in high‐risk STS by center. Abbreviations: G, grade; STS, soft tissue sarcomas.
Figure 5.
Figure 5.
Sample decision tree illustrating the input from one center on postoperative chemotherapy. Abbreviations: G, grade; STS, soft tissue sarcomas.
See this image and copyright information in PMC

References

    1. Skubitz KM, D'Adamo DR. Sarcoma. Mayo Clin Proc 2007;82:1409–1432. - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67:7–30. - PubMed
    1. Gatta G, van der Zwan JM, Casali PG et al. Rare cancers are not so rare: The rare cancer burden in Europe. Eur J Cancer 2011;47:2493–2511. - PubMed
    1. WHO classification of tumors of soft tissue and bone . International Agency for Research on Cancer (IARC), 69372 Lyon Cedex 08, France, 2013: 4th Edition, Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, eds. 10–11.
    1. Clark MA, Fisher C, Judson I et al. Soft‐tissue sarcomas in adults. N Engl J Med 2005;353:701–711. - PubMed